CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 5 enrolled
Drug / intervention
Open-label flexibly dosed milnaciprandrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01780389
NCT01780389Phase 4Completed
CompareCT.gov

Open-label Milnacipran for Persistent Knee Pain One Year After Total Knee Arthroplasty (TKA)

Duke University·interventional·Posted Jan 31, 2013·Updated Feb 6, 2015

In Brief

A Phase 4 clinical trial evaluating Open-label flexibly dosed milnacipran for Knee Pain After Total Knee Arthroplasty and Osteoarthritis Pain. Completed, enrolled 5 participants across 1 site.

Detailed Summary

The current study examines the effects of milnacipran in patients who have chronic persistent knee pain one year or longer after total knee arthroplasty (TKA) to evaluate for a pain-relieving effect.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKnee Pain After Total Knee Arthroplasty, Osteoarthritis Pain
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJan 31, 2013
Enrollment StartOct 1, 2010
Primary CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 13.4 years ago

Interventions

Open-label flexibly dosed milnaciprandrug